Summit Trail Advisors’s QuidelOrtho QDEL Stock Holding History

Summit Trail Advisors’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	99,157 +16,673	+20%	+$220K	0.02%	697
2026 Q1	$1.36M	Buy	82,484 +1,470	+2%	+$36.1K	0.02%	783
2025 Q4	$2.31M	Sell	81,014 -424	-0.5%	-$11.5K	0.04%	328
2025 Q3	$2.4M	Buy	81,438 +67,903	+502%	+$1.86M	0.03%	351
2025 Q2	$390K	Buy	+13,535	New	+$400K	0.01%	819
2024 Q4	–	Sell	-5,272	Closed	-$240K	–	677
2024 Q3	$240K	Buy	+5,272	New	+$213K	0.01%	617

Other funds holding QDEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Summit Trail Advisors's QDEL Position: Q2 2026 in Review

Summit Trail Advisors increased its QuidelOrtho (QDEL) stake by 20% in Q2 2026, buying an estimated $220K and bringing the position to 99,157 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #697.

Summit Trail Advisors first reported a position in QDEL in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.4M in Q3 2025. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

Summit Trail Advisors held 99,157 shares of QuidelOrtho worth $1.74M as of Q2 2026.
Summit Trail Advisors bought 16,673 QuidelOrtho shares in Q2 2026, an estimated $220K.
QuidelOrtho made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #697 holding.
Summit Trail Advisors first reported a position in QuidelOrtho in Q3 2024 and has held it in 6 quarters since.
Summit Trail Advisors's QuidelOrtho position peaked at $2.4M in Q3 2025.
246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.